LXRX
LXRX
NASDAQ · Pharmaceuticals

Lexicon Pharmaceuticals Inc

$1.72
+0.08 (+4.88%)
As of Mar 24, 10:05 PM ET ·
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Buy 8 73%
Hold 3 27%
Sell 0 0%
Price Target
Analyst Price Target +944.8% upside
Low Target $15.16
Average Target $17.97
High Target $22.64
Current Price $1.72
Current
$1.72
Target
$17.97
$15.16 $17.97 avg $22.64
Scenario Analysis
Bear Case
$15.16
781.4%
Low target
Base Case
$17.97
+944.8%
Avg target
Bull Case
$22.64
+1,216.3%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$1.83
-6.0% from high
52-Week Low
$0.31
+463.9% from low
Target vs 52W High
$17.97
+882.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%